Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report.

Roemer, Ségolène; Bissig, Alexandre; Rocca, Alda; Du Pasquier, Renaud; Guex-Crosier, Yan

Roemer, Ségolène; Bissig, Alexandre; Rocca, Alda; Du Pasquier, Renaud; Guex-Crosier, Yan.

Afiliação

Roemer S; Department of Ophthalmology, Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.
Bissig A; Department of Ophthalmology, Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.
Rocca A; Department of Clinical Neurosciences, Neurosurgery Unit, University Hospital CHUV, Lausanne, Switzerland.
Du Pasquier R; Laboratory of Neuroimmunology, Service of Neurology, Department of Clinical Neurosciences, University of Lausanne, CHUV, Lausanne, Switzerland.
Guex-Crosier Y; Department of Ophthalmology, Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.

Klin Monbl Augenheilkd ; 235(4): 476-477, 2018 04.

Article em En | MEDLINE | ID: mdl-29452449

Assuntos

Esclerose Múltipla; Natalizumab/uso terapêutico; Uveíte Intermediária/tratamento farmacológico; Adulto; Anticorpos Monoclonais; Feminino; Humanos; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uveíte Intermediária / Natalizumab / Esclerose Múltipla Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google